The United States of America; as represented by the Secretary Department of Health and Human Services
发明人:
Newman, Amy Hauck,Kumar, Vivek,Shaik, Anver Basha
申请号：
AU2017233716
公开号：
AU2017233716A1
申请日:
2017.03.08
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Disclosed herein novel dopamine D3 receptor selective antagonists/partial agonists compounds with high affinity and metabolic stability useful for the treatment of psychiatric and neurological disorders and as research and diagnostic tools. Also disclosed are methods of making the compounds.
